Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
about
Striking the right immunological balance prevents progression of tuberculosis.A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation.The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing.Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis.Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.Immunological roulette: Luck or something more? Considering the connections between host and environment in TB.Next-Generation Vaccines Based on Bacille Calmette-Guérin.Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases.Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
P2860
Q39437320-C428EB9A-9809-42A1-93D0-5A4E6AD0FBAEQ40107672-7324326E-B27B-4DBD-B32D-B87CEEED9C3DQ40109877-E01C50DC-192B-4F21-87A3-75A6DE79F090Q40116835-881320EA-CE36-436A-936D-1019320A9CF5Q40133620-DC72ABD9-C900-4A97-8957-28519A18C863Q41836016-C6A47FD6-5F9A-46A2-890E-2A506E4A6808Q47141135-DF75069C-23E3-44A9-ABFC-047CA5C6EBF9Q47553632-0B4D5A10-48EB-4B03-9685-390E5ECFC24DQ48156066-D513E4BB-57AB-4B2C-92BD-D7BFC4072488Q49829375-E34FBDC1-1E88-4D2A-AFB7-98961E0B4A14Q49973045-20558383-9AB4-402F-9CDC-3D4C851650E1Q50531820-CCA1B606-5289-42D6-9234-7D4D7156606CQ54952694-7BAE10D3-8866-4EFD-92DA-BE590CF3A632Q55431567-4E085C80-AB9C-4824-BB1B-35BD9653BD35
P2860
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@ast
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@en
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@nl
type
label
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@ast
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@en
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@nl
prefLabel
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@ast
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@en
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@nl
P2093
P2860
P50
P356
P1476
Targeting dendritic cells to a ...... tuberculosis vaccine efficacy
@en
P2093
Darrell J Irvine
Jay K Kolls
Maxim N Artyomov
Mushtaq Ahmed
Radha Gopal
Shabaana A Khader
Terry D Connell
William Horne
P2860
P2888
P356
10.1038/NCOMMS13894
P407
P577
2016-12-22T00:00:00Z
P6179
1023176648